MoneyWorks4Me

Kimia Biosciences informs about issue of duplicate share certificate

22 Sep 2023 Evaluate
Pursuant to regulation 39(3) of SEBI (LODR) 2015, Kimia Biosciences has informed that the Company has received the intimation from its RTA regarding receiving request for issuance of duplicate share certificates.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..